Filing Details
- Accession Number:
- 0001127602-15-021077
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-19 13:04:36
- Reporting Period:
- 2015-06-18
- Filing Date:
- 2015-06-19
- Accepted Time:
- 2015-06-19 13:04:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 799729 | Parexel International Corp | PRXL | Services-Commercial Physical & Biological Research (8731) | 042776269 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1278042 | A Mark Goldberg | Parexel International Corporation 195 West Street Waltham MA 02451 | President & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-18 | 6,402 | $30.18 | 107,770 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-06-18 | 5,105 | $21.97 | 112,875 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-18 | 11,507 | $70.03 | 101,368 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-06-18 | 6,402 | $0.00 | 6,402 | $30.18 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-06-18 | 5,105 | $0.00 | 5,105 | $21.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-09-11 | No | 4 | M | Direct | |
| 4,220 | 2018-09-15 | No | 4 | M | Direct |
Footnotes
- The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the reporting person.
- This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $69.99- $70.07. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average sale price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.
- Options become exercisable in increments of 25% of the total shares granted commencing on the first anniversary of the date of grant.
Billionaire Hedge Funds
